VASCULAR SOLUTIONS INC
10-Q, EX-27.1, 2000-08-03
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: VASCULAR SOLUTIONS INC, 10-Q, 2000-08-03
Next: VASCULAR SOLUTIONS INC, 10-Q, EX-27.2, 2000-08-03



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR THE THREE-MONTH PERIOD ENDED JUNE 30, 2000 AND 1999 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             APR-01-2000             APR-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                       5,088,522                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  773,550                       0
<ALLOWANCES>                                  (20,000)                       0
<INVENTORY>                                  1,143,897                       0
<CURRENT-ASSETS>                             7,310,607                       0
<PP&E>                                       1,446,003                       0
<DEPRECIATION>                               (574,482)                       0
<TOTAL-ASSETS>                               8,182,128                       0
<CURRENT-LIABILITIES>                        1,668,888                       0
<BONDS>                                              0                       0
                                0                       0
                                     37,778                       0
<COMMON>                                        52,781                       0
<OTHER-SE>                                   6,422,681                       0
<TOTAL-LIABILITY-AND-EQUITY>                 8,182,128                       0
<SALES>                                        708,250                 307,500
<TOTAL-REVENUES>                               708,250                 307,500
<CGS>                                          353,706                 256,393
<TOTAL-COSTS>                                3,266,170               1,950,161
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                            (2,911,626)             (1,899,054)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (2,911,626)             (1,899,054)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (2,818,978)             (1,818,892)
<EPS-BASIC>                                      (.53)                   (.49)
<EPS-DILUTED>                                    (.53)                   (.49)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission